Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Diabetes Care|April 11, 2020
Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.STimothy J Garrett, Philip Atkinson, Eoin P Quinlivan, et al.Diabetes Care|November 22, 2014
Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetesMelissa A Buryk, H-Michael Dosch, Ingrid Libman, et al.Journal of Autoimmunity|August 5, 2014
Compromised central tolerance of ICA69 induces multiple organ autoimmunityYong Fan, Giulio Gualtierotti, Asako Tajima, et al.American Journal of Medical Genetics. Part A|September 27, 2015
Isodicentric Y mosaicism involving a 46, XX cell line: Implications for managementLauren E Hipp, Lauren H Mohnach, Sainan Wei, et al.Journal of Autoimmunity|August 21, 2018
Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetesLi Zhang, Tomasz Sosinowski, Aaron R Cox, et al.Pediatric Diabetes|January 5, 2006
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodiesMassimo Pietropaolo, Shui Yu, Ingrid M Libman, et al.JAMA Network Open|October 28, 2021
Feasibility of Electronic Health Record Assessment of 6 Pediatric Type 1 Diabetes Self-management Habits and Their Association With Glycemic OutcomesJoyce M Lee, Andrea Rusnak, Ashley Garrity, et al.Pediatric Diabetes|June 6, 2009
Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutationInas H Thomas, Natinder K Saini, Amita Adhikari, et al.Plos One|September 17, 2014
Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetesAngela Subauste, Roberto Gianani, Annette M Chang, et al.Endocrinology|April 13, 2010
Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetesMichael P Morran, Anna Casu, Vincent C Arena, et al.Pageof 8